Introduction - Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure.
Topic:
Diabetes and the Heart
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim/Lilly
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Professor Francesco Cosentino
Karolinska University Hospital, Stockholm (Sweden)
24
presentations
0
follower
2 more presentations in this session
Targeting SGLT2 inhibition in cardiology: what is the profile of benefit?
Speaker: Professor N. Marx (Aachen, DE)
Panel discussion: discussing the benefits in cardiovascular risk, diabetes & heart failure.
Speaker: Professor S. Jacob (Villingen, DE) Professor N. Marx (Aachen, DE) Professor F. Cosentino (Stockholm, SE) Professor J. Deanfield (London, GB)
Access the full session
Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure
Speakers:
Professor F. Cosentino, Professor N. Marx, Professor S. Jacob, Professor N. Marx, Professor F. Cosentino...
About the event
ESC 365 is supported by
